0000899243-20-029545.txt : 20201028
0000899243-20-029545.hdr.sgml : 20201028
20201028175639
ACCESSION NUMBER: 0000899243-20-029545
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201026
FILED AS OF DATE: 20201028
DATE AS OF CHANGE: 20201028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOLMLUND JON T
CENTRAL INDEX KEY: 0001227367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 201269860
BUSINESS ADDRESS:
STREET 1: 2292 FARADAY AVE
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 7609319200
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-26
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001227367
HOLMLUND JON T
C/O GALERA THERAPEUTICS, INC.,
2 W LIBERTY BLVD #100
MALVERN
PA
19355
0
1
0
0
Chief Medical Officer
Common Stock
2020-10-26
4
M
0
2244
2.43
A
2244
D
Common Stock
2020-10-26
4
S
0
2244
15.00
D
0
D
Stock Option
2.43
2020-10-26
4
M
0
2244
0.00
D
2026-03-31
Common Stock
2244
108898
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
The option has fully vested and is currently exercisable.
/s/ Christopher Degnan, Attorney-in-Fact for Jon T. Holmlund
2020-10-28